» Articles » PMID: 30219925

The Peroxisome: an Update on Mysteries 2.0

Overview
Publisher Springer
Date 2018 Sep 17
PMID 30219925
Citations 127
Authors
Affiliations
Soon will be listed here.
Abstract

Peroxisomes are key metabolic organelles, which contribute to cellular lipid metabolism, e.g. the β-oxidation of fatty acids and the synthesis of myelin sheath lipids, as well as cellular redox balance. Peroxisomal dysfunction has been linked to severe metabolic disorders in man, but peroxisomes are now also recognized as protective organelles with a wider significance in human health and potential impact on a large number of globally important human diseases such as neurodegeneration, obesity, cancer, and age-related disorders. Therefore, the interest in peroxisomes and their physiological functions has significantly increased in recent years. In this review, we intend to highlight recent discoveries, advancements and trends in peroxisome research, and present an update as well as a continuation of two former review articles addressing the unsolved mysteries of this astonishing organelle. We summarize novel findings on the biological functions of peroxisomes, their biogenesis, formation, membrane dynamics and division, as well as on peroxisome-organelle contacts and cooperation. Furthermore, novel peroxisomal proteins and machineries at the peroxisomal membrane are discussed. Finally, we address recent findings on the role of peroxisomes in the brain, in neurological disorders, and in the development of cancer.

Citing Articles

LncRNA Gm35585 transcriptionally activates the peroxidase EHHADH against diet-induced fatty liver.

Jin M, Lu Q, Xia N, Fan X, Zhang Z, Huang X Exp Mol Med. 2025; .

PMID: 40082671 DOI: 10.1038/s12276-025-01420-5.


Integrative Omics reveals changes in the cellular landscape of peroxisome-deficient yeast cells.

Kosir T, Das H, Pedersen M, Richard A, Anteghini M, Martins Dos Santos V Microb Cell. 2025; 12:9-33.

PMID: 40012703 PMC: 11862644. DOI: 10.15698/mic2025.02.842.


Functional analysis of cancer-associated germline risk variants.

Kellman L, Neela P, Srinivasan S, Siprashvili Z, Shanderson R, Hong A Nat Genet. 2025; 57(3):718-728.

PMID: 39962238 DOI: 10.1038/s41588-024-02070-5.


Modelling Peroxisomal Disorders in Zebrafish.

Jiang C, Schrader M Cells. 2025; 14(2).

PMID: 39851575 PMC: 11764017. DOI: 10.3390/cells14020147.


Peroxisome and pexophagy in neurological diseases.

Xu W, Yan J, Shao A, Lenahan C, Gao L, Wu H Fundam Res. 2024; 4(6):1389-1397.

PMID: 39734532 PMC: 11670711. DOI: 10.1016/j.fmre.2023.04.016.


References
1.
Went P, Sauter G, Oberholzer M, Bubendorf L . Abundant expression of AMACR in many distinct tumour types. Pathology. 2006; 38(5):426-32. DOI: 10.1080/00313020600922470. View

2.
Schrader M, Fahimi H . The peroxisome: still a mysterious organelle. Histochem Cell Biol. 2008; 129(4):421-40. PMC: 2668598. DOI: 10.1007/s00418-008-0396-9. View

3.
Benjamin D, Cozzo A, Ji X, Roberts L, Louie S, Mulvihill M . Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity. Proc Natl Acad Sci U S A. 2013; 110(37):14912-7. PMC: 3773741. DOI: 10.1073/pnas.1310894110. View

4.
Lloyd M, Darley D, Wierzbicki A, Threadgill M . Alpha-methylacyl-CoA racemase--an 'obscure' metabolic enzyme takes centre stage. FEBS J. 2008; 275(6):1089-102. DOI: 10.1111/j.1742-4658.2008.06290.x. View

5.
Islinger M, Abdolzade-Bavil A, Liebler S, Weber G, Volkl A . Assessing heterogeneity of peroxisomes: isolation of two subpopulations from rat liver. Methods Mol Biol. 2012; 909:83-96. DOI: 10.1007/978-1-61779-959-4_6. View